FDA Import Refusal 1FX-7684022-2/30002/1 — GLENMARK PHARMACEUTICALS LTD
The FDA refused shipment 1FX-7684022-2/30002/1 from GLENMARK PHARMACEUTICALS LTD (India) on Aug 25, 2026. The refused product falls under Drugs and Biologics — NAPROXEN SODIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 25, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GDA50 NAPROXEN SODIUM (ANTI-INFLAMMATORY)
- Charges
- 75